Forte Biosciences Inc (FBRX)
0.6902
+0.02
(+2.86%)
USD |
NASDAQ |
May 02, 16:00
Forte Biosciences 1 Year Total Returns (Daily): -35.50% for May 2, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 02, 2024 | -35.50% |
May 01, 2024 | -37.87% |
April 30, 2024 | -30.72% |
April 29, 2024 | -32.24% |
April 26, 2024 | -32.42% |
April 25, 2024 | -29.62% |
April 24, 2024 | -31.44% |
April 23, 2024 | -30.97% |
April 22, 2024 | -32.71% |
April 19, 2024 | -30.75% |
April 18, 2024 | -26.42% |
April 17, 2024 | -31.48% |
April 16, 2024 | -32.07% |
April 15, 2024 | -34.26% |
April 12, 2024 | -34.84% |
April 11, 2024 | -33.94% |
April 10, 2024 | -33.64% |
April 09, 2024 | -33.81% |
April 08, 2024 | -35.69% |
April 05, 2024 | -30.11% |
April 04, 2024 | -27.00% |
April 03, 2024 | -30.81% |
April 02, 2024 | -28.95% |
April 01, 2024 | -29.95% |
March 28, 2024 | -29.36% |
Date | Value |
---|---|
March 27, 2024 | -28.81% |
March 26, 2024 | -28.08% |
March 25, 2024 | -28.05% |
March 22, 2024 | -28.18% |
March 21, 2024 | -29.79% |
March 20, 2024 | -28.94% |
March 19, 2024 | -34.00% |
March 18, 2024 | -35.68% |
March 15, 2024 | -37.16% |
March 14, 2024 | -34.33% |
March 13, 2024 | -34.44% |
March 12, 2024 | -32.79% |
March 11, 2024 | -29.09% |
March 08, 2024 | -24.29% |
March 07, 2024 | -23.44% |
March 06, 2024 | -28.16% |
March 05, 2024 | -32.10% |
March 04, 2024 | -34.27% |
March 01, 2024 | -27.64% |
February 29, 2024 | -33.06% |
February 28, 2024 | -29.41% |
February 27, 2024 | -33.48% |
February 26, 2024 | -32.91% |
February 23, 2024 | -33.65% |
February 22, 2024 | -35.83% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-97.14%
Minimum
May 23 2022
500.5%
Maximum
Dec 17 2020
-15.01%
Average
-50.00%
Median
Oct 20 2023
1 Year Total Returns (Daily) Benchmarks
CEL-SCI Corp | -37.82% |
AIM ImmunoTech Inc | -16.66% |
IGC Pharma Inc | 51.16% |
NovaBay Pharmaceuticals Inc | -91.96% |
Protalix BioTherapeutics Inc | -56.06% |